Time course of dopamine neuron loss and glial response in the 6-OHDA striatal mouse model of Parkinson's disease

作者: Simon R.W. Stott , Roger A. Barker

DOI: 10.1111/EJN.12459

关键词:

摘要: The 6-hydroxydopamine (6-OHDA) neurotoxic lesion of the midbrain dopamine (DA) system is one most widely used techniques for modelling Parkinson's disease in rodents. majority studies using this approach, however, largely limit their analysis to lesioning acutely, and looking at behavioural deficits number surviving tyrosine hydroxylase (TH)-stained cells midbrain. Here we have analysed additional characteristics that occur following intrastriatal delivery 6-OHDA, providing better understanding neurodegenerative process. Female C57/Black mice were given lesions 10 weeks old, killed several different time points postoperatively (3 6 h, 1, 3, 6, 9 12 days). While detrimental effect toxin on TH+ fibres striatum was immediate, found loss dendritic fibres, reduction cell size intensity TH expression, eventual neurons substantia nigra delayed days post-surgery. We also investigated expression various transcription factors proteins expressed by DA lesioning, observed changes Aldh1a1 (aldehyde dehydrogenase 1 family, member A1) as process evolved. Extracellularly, looked microglia astrocytes reaction 6-OHDA striatal lesion, a delay response proliferation nigra. In summary, work highlights aspects mouse model can be applied future therapeutic interventions.

参考文章(78)
Susan Duty, Peter Jenner, Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease British Journal of Pharmacology. ,vol. 164, pp. 1357- 1391 ,(2011) , 10.1111/J.1476-5381.2011.01426.X
Jessica Kauhausen, Lachlan H. Thompson, Clare L. Parish, Cell intrinsic and extrinsic factors contribute to enhance neural circuit reconstruction following transplantation in Parkinsonian mice The Journal of Physiology. ,vol. 591, pp. 77- 91 ,(2013) , 10.1113/JPHYSIOL.2012.243063
C. L. Parish, D. I. Finkelstein, J. Drago, E. Borrelli, M. K. Horne, The Role of Dopamine Receptors in Regulating the Size of Axonal Arbors The Journal of Neuroscience. ,vol. 21, pp. 5147- 5157 ,(2001) , 10.1523/JNEUROSCI.21-14-05147.2001
Peter Åkerud, Josep M. Canals, Evan Y. Snyder, Ernest Arenas, Neuroprotection through Delivery of Glial Cell Line-Derived Neurotrophic Factor by Neural Stem Cells in a Mouse Model of Parkinson's Disease The Journal of Neuroscience. ,vol. 21, pp. 8108- 8118 ,(2001) , 10.1523/JNEUROSCI.21-20-08108.2001
Christian Winkler, Hansjörg Sauer, Chong S. Lee, Anders Björklund, Short-term GDNF treatment provides long-term rescue of lesioned nigral dopaminergic neurons in a rat model of Parkinson's disease. The Journal of Neuroscience. ,vol. 16, pp. 7206- 7215 ,(1996) , 10.1523/JNEUROSCI.16-22-07206.1996
Angélique Virgone-Carlotta, Josselin Uhlrich, Muhammad Numan Akram, Denis Ressnikoff, Fabrice Chrétien, Chantal Domenget, Romain Gherardi, Geneviève Despars, Pierre Jurdic, Jérôme Honnorat, Serge Nataf, Monique Touret, Mapping and kinetics of microglia/neuron cell-to-cell contacts in the 6-OHDA murine model of Parkinson's disease Glia. ,vol. 61, pp. 1645- 1658 ,(2013) , 10.1002/GLIA.22546
FranciscoA Perez, WendyR Curtis, RichardD Palmiter, Parkin-deficient mice are not more sensitive to 6-hydroxydopamine or methamphetamine neurotoxicity. BMC Neuroscience. ,vol. 6, pp. 71- 71 ,(2005) , 10.1186/1471-2202-6-71
Christian Wolfrum, Esra Asilmaz, Edlira Luca, Jeffrey M. Friedman, Markus Stoffel, Foxa2 regulates lipid metabolism and ketogenesis in the liver during fasting and in diabetes Nature. ,vol. 432, pp. 1027- 1032 ,(2004) , 10.1038/NATURE03047
Sang J. Na, Anthony G. DiLella, Edward V. Lis, Keith Jones, David M. Levine, David J. Stone, J. F. Hess, Molecular Profiling of a 6-Hydroxydopamine Model of Parkinson’s Disease Neurochemical Research. ,vol. 35, pp. 761- 772 ,(2010) , 10.1007/S11064-010-0133-3
S.-L. Ang, Transcriptional control of midbrain dopaminergic neuron development. Development. ,vol. 133, pp. 3499- 3506 ,(2006) , 10.1242/DEV.02501